Submission of 52nd Annual Report of the Company including Notice of 52nd Annual General Meeting of the Company.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics Ltd has submitted its 52nd Annual Report for FY 2024-25 along with the AGM notice to BSE and NSE. The 52nd Annual General Meeting is scheduled for Monday, September 29, 2025, at 3:00 PM, held entirely through video conferencing. The remote e-voting window runs from September 25 (9:00 AM) to September 28 (5:00 PM), with a cut-off date of September 22, 2025. Key resolutions on the AGM agenda include adoption of audited standalone and consolidated financial statements, re-appointment of Whole-Time Director Shri Brijmohan M. Dhoot (retiring by rotation), ratification of cost auditor remuneration of Rs. 1,10,000, approval of material related party transactions with limits of up to Rs. 50 crore each with several promoter-related entities, and appointment of Ragini Chokshi & Co. as secretarial auditor for a 5-year term (FY 2025-26 to FY 2029-30). The annual report is available on the company's website and the NSDL e-voting portal.
This is a routine compliance filing with no direct impact on share price. Shareholders should review the AGM agenda items — particularly the related party transaction approvals and director re-appointment — and exercise their voting rights during the e-voting window.